跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CANDEZA 8/12.5 mg TABLETS - SFDA Drug Approval Details
Approvals
/
SFDA
/
CANDEZA 8/12.5 mg TABLETS
Authorized
GENERIC
CANDEZA 8/12.5 mg TABLETS
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
774e481861a9e00b
Company
Unknown
Type
Generic
Approval Details
Approval Id
774e481861a9e00b
Drug Approval Sfda Name
CANDEZA 8/12.5 mg TABLETS
Trade Name
CANDEZA 8/12.5 mg TABLETS
Generic Name
CANDESARTAN CILEXETIL,HYDROCHLOROTHIAZIDE
Register Number
1706257568
Register Year
2018
Drug Type
Generic
Route Of Administration
Oral use
Package Type
Blister
Package Size
28
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 30°c
Shelf Life
24 Months
Distribution Site
Pharmacy
Description Code
14000000831-28.5-100000073664
Price
23.45
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
774e481861a9e00b
Type
Generic
Back to SFDA Approvals